Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Team Grant: Health Challenges in Chronic Inflammation Initiative (LOI)

University of Manitoba

$12,930.00

Defining the burden and managing the effects of psychiatric comorbidity in chronic immunoinflammatory disease

EF 2012-13

Résumé
This Team Grant creates a multi-disciplinary team with complementary expertise. Our team will focus on the problem of psychiatric comorbidity (such as depression and anxiety disorders) in persons with chronic immuno-inflammatory diseases including inflammatory bowel disease (IBD), multiple sclerosis (MS) and rheumatoid arthritis (RA). The research program has several objectives. First, we will identify the frequency of psychiatric comorbidities among persons with IBD, MS, and RA as compared to the general population, determining how this varies according to age, sex, region and socioeconomic status. Second, we will assess the impact of psychiatric comorbidity on MS in three ways. By focusing on hospitalizations, mortality and health-related quality of life we will gain a broad perspective on how psychiatric comorbidity influences health. By focusing on work disability we will gain an understanding of how psychiatric comorbidity influences participation in work and social roles. Finally, we work with primary care physicians to determine the best way to diagnose and treat psychiatric comorbidity in persons with chronic immuno-inflammatory diseases. We will partner primary care physicians, advocacy groups including the Crohn's and Colitis Foundation, MS Society of Canada, and Arthritis Society to ensure that our findings are disseminated. Anticipated benefits from our population-based research program include better recognition of the magnitude of psychiatric comorbidities and their impact on IBD, MS and RA; development of strategies to manage these comorbidities; and development of generalizable research strategies to evaluate and manage comorbidities in chronic immuno-inflammatory diseases.
Programme
Team Grant: Health Challenges in Chronic Inflammation Initiative (LOI)
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
276892
Name
Marrie Ruth Ann
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Health systems / services
Prcname2
Team Grant: Health Challenges in Chronic Inflammation Initiative (LOI)
Projecttitle
Defining the burden and managing the effects of psychiatric comorbidity in chronic immunoinflammatory disease
Programtype2
Operating Grants
Orgnameinp2
University of Manitoba
Cihramount2
$12,930
Cihrequipment2
$0
Programname2
Team Grant: Health Challenges in Chronic Inflammation Initiative (LOI)
Keyworddelim
Administrative Data; Cohort Study; Health Care Utilization; Inflammatory Bowel Disease; Mental Health; Multiple Sclerosis; Population Health; Primary Care; Rheumatoid Arthritis
Abstract
This Team Grant creates a multi-disciplinary team with complementary expertise. Our team will focus on the problem of psychiatric comorbidity (such as depression and anxiety disorders) in persons with chronic immuno-inflammatory diseases including inflammatory bowel disease (IBD), multiple sclerosis (MS) and rheumatoid arthritis (RA). The research program has several objectives. First, we will identify the frequency of psychiatric comorbidities among persons with IBD, MS, and RA as compared to the general population, determining how this varies according to age, sex, region and socioeconomic status. Second, we will assess the impact of psychiatric comorbidity on MS in three ways. By focusing on hospitalizations, mortality and health-related quality of life we will gain a broad perspective on how psychiatric comorbidity influences health. By focusing on work disability we will gain an understanding of how psychiatric comorbidity influences participation in work and social roles. Finally, we work with primary care physicians to determine the best way to diagnose and treat psychiatric comorbidity in persons with chronic immuno-inflammatory diseases. We will partner primary care physicians, advocacy groups including the Crohn's and Colitis Foundation, MS Society of Canada, and Arthritis Society to ensure that our findings are disseminated. Anticipated benefits from our population-based research program include better recognition of the magnitude of psychiatric comorbidities and their impact on IBD, MS and RA; development of strategies to manage these comorbidities; and development of generalizable research strategies to evaluate and manage comorbidities in chronic immuno-inflammatory diseases.
Competitiondate
201211
Approvedterm2
1 yr 0 mth
Pinamesdelim
Marrie, Ruth Ann; Bernstein, Charles N; El-Gabalawy, Hani S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $12,930~ $0~